ArticleVaccines2022
Assessing COVID-19 Booster Hesitancy and Its Correlates: An Early Evidence from India.
Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- How well does vaccine literacy predict intention to vaccinate and vaccination status? A systematic review and meta-analysis.Human vaccines & immunotherapeutics · 2024Pooled it
- COVID-19 vaccine acceptance and hesitancy in Indian context: a systematic review and meta-analysis.Pathogens and global health · 2024Pooled it
- Utilization of the multi-theory model (MTM) of health behavior change to explain health behaviors: A systematic review.Health promotion perspectives · 2024Pooled it
- Vaccine Literacy and Vaccination: A Systematic Review.International journal of public health · 2023Pooled it
- Epidemiological and clinical characteristics of vaccinated COVID-19 patients: A meta-analysis and systematic review.International journal of immunopathology and pharmacologyPooled it
- Acceptance of the COVID-19 Booster Vaccine Amid the Omicron JN.1 Surge in Southern Bangladesh: A Comparative Analysis of Rural-Urban Disparities.Risk analysis : an official publication of the Society for Risk Analysis · 2026Observational
- Using the Diffusion of Innovation Theory to Understand COVID-19 Booster Hesitancy in Adults.International journal of environmental research and public health · 2026Article
- Article
- Assessment of determinant factors of willingness to pay for dengue vaccine: multicenter and cross-sectional study in Southeast Sulawesi, Indonesia.Clinical and experimental vaccine research · 2025Article
- Article
- Validation of an Arabic tool for assessing vaccination literacy: A factor and Rasch analysis.Human vaccines & immunotherapeutics · 2024Article
- Healthcare workers' willingness to receive COVID-19 booster dose and associated factors in the Democratic Republic of the Congo.Human vaccines & immunotherapeutics · 2024Article
- Global disparities in COVID-19 vaccine booster dose (VBD) acceptance and hesitancy: An updated narrative review.Vaccine: X · 2024Review
- Article
- The relationship between influenza vaccine hesitancy and vaccine literacy among youth and adults in China.Frontiers in immunology · 2024Article
- Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium.Vaccine: X · 2024Article
- COVID-19 vaccine literacy: A scoping review.Human vaccines & immunotherapeutics · 2023Article
- Article
- Factors for hesitancy towards vaccination against COVID-19 among the adult population in Puducherry, India - a cross sectional study.BMC public health · 2023Article
- Acceptance of COVID-19 vaccine booster dose among the people of Bangladesh: A cross-sectional study.Heliyon · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of SARS-CoV-2 mutants, waning immunity, and breakthrough infections prompted the use of booster doses of the COVID-19 vaccine to fight against the pandemic. India started booster doses in January 2022 and it is critical to determine the intention of booster dose uptake and its correlates. Therefore, the current cross-sectional study aimed to investigate booster dose acceptability and associated predictors among the Indian population. A convenience sampling technique was utilized to recruit a sample of 687 Indian residents. A 55-item psychometric validated survey tool was used to assess booster dose acceptability, vaccine literacy and vaccine confidence. Univariate, bivariate, and multivariate statistical methods were used to analyze the data. Over 50% of participants reported their willingness to take the booster dose. Among the group not willing to take the booster dose (n = 303, 44.1%), a significantly larger proportion of respondents were unvaccinated with the primary series (12.2% vs. 5.2%, p < 0.001), had an annual income below 2.96 lacs/annum (52.8% vs. 33.1, p < 0.001), were residents of rural areas (38.0% vs. 23.2%, p < 0.001), were not living with vulnerable individuals (78.5% vs. 65.2%, p < 0.001) and did not have family/friends who had tested positive for COVID-19 (54.6% vs. 35.1%, p = 0.001). Demographic, vaccine variables and multi-theory model subscales to predict the initiation of booster dose among hesitant participants were statistically significant, R2 = 0.561, F (26, 244) = 11.978, p < 0.001; adjusted R2 = 0.514. Findings of this study highlight the need to develop evidence-based interventions to promote vaccine uptake, particularly among hard-to-reach communities living in developing countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.